PREVIOUS ISSUE NEXT ISSUE
March 2017 Cover-24.jpg
Should we take another look at antenatal corticosteroids?The risks of administering ACS at late term and term remain unknown, says this MFM specialist.
Bilateral salpingectomy: An opportunity to reduce cancer riskThe data, say the authors, support counseling post-reproductive women undergoing hysterectomy about the risks and benefits of retaining their fallopian tubes.
OB ignores nursing supervisor, fractures infant’s skull"Reckless" forceps use ends in disaster.
Medical marijuana: An oxymoron and a risk to fetusesIt's never appropriate in pregnancy, says our editor in chief.
Trimester zero (Part 1 of 2)Preconception care is primary prevention. The goal is to affirm pregnancy intention, reduce any potential harm, and recognize modifiable risk factors related to pregnancy while stratifying pregnancies on a continuum of low- to high-risk.
Readers React: In defense of breast density notification lawsWe read with interest the article “Breast density laws: Are you in compliance?” [December 2016 Contemporary OB/GYN]. We appreciated the perspective of our gynecologist colleagues. We would like to help clarify and give context to some of the information in the article.
Readers reactReaders write in about their thoughts on the annual labor force survey, the conundrum presented by cesarean delivery and defensive medicine, more information on treating women who have been the victim of sexual assault, and what is adding to the stress of the job.
SMFM Consult: Ultrasound in the cfDNA eraThe society's recommendations for women who are undergoing both ultrasound and cfDNA screening.
PREVIOUS ISSUE NEXT ISSUE